Jacek Kwiecinski1,2, Sebastien Cadet1, Marwa Daghem3, Martin L Lassen1, Damini Dey1, Marc R Dweck3, Daniel S Berman1, David E Newby3, Piotr J Slomka4. 1. Departments of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA. 2. Department of Interventional Cardiology and Angiology, Institute of Cardiology, Alpejska 42, 04-628, Warsaw, Poland. 3. BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK. 4. Departments of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA. piotr.slomka@cshs.org.
Abstract
PURPOSE: 18F-sodium fluoride (18F-NaF) has shown promise in assessing disease activity in coronary arteries, but currently used measures of activity - such as maximum target to background ratio (TBRmax) - are defined by single pixel count values. We aimed to develop a novel coronary-specific measure of 18F-NaF PET reflecting activity throughout the entire coronary vasculature (coronary microcalcification activity [CMA]). METHODS: Patients with recent myocardial infarction and multi-vessel coronary artery disease underwent 18F-NaF PET and coronary CT angiography. We assessed the association between coronary 18F-NaF uptake (both TBRmax and CMA) and coronary artery calcium scores (CACS) as well as low attenuation plaque (LAP, attenuation < 30 Hounsfield units) volume. RESULTS: In 50 patients (64% males, 63 ± 7 years), CMA and TBRmax were higher in vessels with LAP compared to those without LAP (1.09 [0.02, 2.34] versus 0.0 [0.0, 0.0], p < 0.001 and 1.23 [1.16, 1.37] versus 1.04 [0.93, 1.11], p < 0.001). Compared to a TBRmax threshold of 1.25, CMA > 0 had a higher diagnostic accuracy for detection of LAP: sensitivity of 93.1 (83.3-98.1)% versus 58.6 (44.9-71.4)% and a specificity of 95.7 (88.0-99.1)% versus 80.0 (68.7-88.6)% (both p < 0.001). 18F-NaF uptake assessed by CMA correlated more closely with LAP (r = 0.86, p < 0.001) than the CT calcium score (r = 0.39, p < 0.001), with these associations outperforming those observed for TBRmax values (LAP r = 0.63, p < 0.001; CT calcium score r = 0.30, p < 0.001). CONCLUSIONS: Automated assessment of disease activity across the entire coronary vasculature is feasible using 18F-NaF CMA, providing a single measurement that has closer agreement with CT markers of plaque vulnerability than more traditional measures of plaque activity.
PURPOSE: 18F-sodium fluoride (18F-NaF) has shown promise in assessing disease activity in coronary arteries, but currently used measures of activity - such as maximum target to background ratio (TBRmax) - are defined by single pixel count values. We aimed to develop a novel coronary-specific measure of 18F-NaF PET reflecting activity throughout the entire coronary vasculature (coronary microcalcification activity [CMA]). METHODS: Patients with recent myocardial infarction and multi-vessel coronary artery disease underwent 18F-NaF PET and coronary CT angiography. We assessed the association between coronary 18F-NaF uptake (both TBRmax and CMA) and coronary artery calcium scores (CACS) as well as low attenuation plaque (LAP, attenuation < 30 Hounsfield units) volume. RESULTS: In 50 patients (64% males, 63 ± 7 years), CMA and TBRmax were higher in vessels with LAP compared to those without LAP (1.09 [0.02, 2.34] versus 0.0 [0.0, 0.0], p < 0.001 and 1.23 [1.16, 1.37] versus 1.04 [0.93, 1.11], p < 0.001). Compared to a TBRmax threshold of 1.25, CMA > 0 had a higher diagnostic accuracy for detection of LAP: sensitivity of 93.1 (83.3-98.1)% versus 58.6 (44.9-71.4)% and a specificity of 95.7 (88.0-99.1)% versus 80.0 (68.7-88.6)% (both p < 0.001). 18F-NaF uptake assessed by CMA correlated more closely with LAP (r = 0.86, p < 0.001) than the CT calcium score (r = 0.39, p < 0.001), with these associations outperforming those observed for TBRmax values (LAP r = 0.63, p < 0.001; CT calcium score r = 0.30, p < 0.001). CONCLUSIONS: Automated assessment of disease activity across the entire coronary vasculature is feasible using 18F-NaF CMA, providing a single measurement that has closer agreement with CT markers of plaque vulnerability than more traditional measures of plaque activity.
Authors: Michaela M Hell; Manish Motwani; Yuka Otaki; Sebastien Cadet; Heidi Gransar; Romalisa Miranda-Peats; Jacob Valk; Piotr J Slomka; Victor Y Cheng; Alan Rozanski; Balaji K Tamarappoo; Sean Hayes; Stephan Achenbach; Daniel S Berman; Damini Dey Journal: Eur Heart J Cardiovasc Imaging Date: 2017-12-01 Impact factor: 6.875
Authors: Percy Lee; Dilani K Weerasuriya; Philip W Lavori; Andrew Quon; Wendy Hara; Peter G Maxim; Quynh-Thu Le; Heather A Wakelee; Jessica S Donington; Edward E Graves; Billy W Loo Journal: Int J Radiat Oncol Biol Phys Date: 2007-10-01 Impact factor: 7.038
Authors: Daniele Massera; Mhairi K Doris; Sebastien Cadet; Jacek Kwiecinski; Tania A Pawade; Frederique E C M Peeters; Damini Dey; David E Newby; Marc R Dweck; Piotr J Slomka Journal: J Nucl Cardiol Date: 2018-11-29 Impact factor: 5.952
Authors: Jason M Tarkin; Francis R Joshi; Nicholas R Evans; Mohammed M Chowdhury; Nichola L Figg; Aarti V Shah; Lakshi T Starks; Abel Martin-Garrido; Roido Manavaki; Emma Yu; Rhoda E Kuc; Luigi Grassi; Roman Kreuzhuber; Myrto A Kostadima; Mattia Frontini; Peter J Kirkpatrick; Patrick A Coughlin; Deepa Gopalan; Tim D Fryer; John R Buscombe; Ashley M Groves; Willem H Ouwehand; Martin R Bennett; Elizabeth A Warburton; Anthony P Davenport; James H F Rudd Journal: J Am Coll Cardiol Date: 2017-04-11 Impact factor: 24.094
Authors: Rachael O Forsythe; Marc R Dweck; Olivia M B McBride; Alex T Vesey; Scott I Semple; Anoop S V Shah; Philip D Adamson; William A Wallace; Jakub Kaczynski; Weiyang Ho; Edwin J R van Beek; Calum D Gray; Alison Fletcher; Christophe Lucatelli; Aleksander Marin; Paul Burns; Andrew Tambyraja; Roderick T A Chalmers; Graeme Weir; Neil Mitchard; Adriana Tavares; Jennifer M J Robson; David E Newby Journal: J Am Coll Cardiol Date: 2018-02-06 Impact factor: 24.094
Authors: J H F Rudd; E A Warburton; T D Fryer; H A Jones; J C Clark; N Antoun; P Johnström; A P Davenport; P J Kirkpatrick; B N Arch; J D Pickard; P L Weissberg Journal: Circulation Date: 2002-06-11 Impact factor: 29.690
Authors: Brett W Sperry; Timothy M Bateman; Esma A Akin; Paco E Bravo; Wengen Chen; Vasken Dilsizian; Fabien Hyafil; Yiu Ming Khor; Robert J H Miller; Riemer H J A Slart; Piotr Slomka; Hein Verberne; Edward J Miller; Chi Liu Journal: J Nucl Cardiol Date: 2022-07-21 Impact factor: 3.872
Authors: Jacek Kwiecinski; Evangelos Tzolos; Alexander J Fletcher; Jennifer Nash; Mohammed N Meah; Sebastien Cadet; Philip D Adamson; Kajetan Grodecki; Nikhil Joshi; Michelle C Williams; Edwin J R van Beek; Chi Lai; Adriana A S Tavares; Mark G MacAskill; Damini Dey; Andrew H Baker; Jonathon Leipsic; Daniel S Berman; Stephanie L Sellers; David E Newby; Marc R Dweck; Piotr J Slomka Journal: JACC Cardiovasc Imaging Date: 2022-02-16
Authors: Jacek Kwiecinski; Evangelos Tzolos; Philip D Adamson; Sebastien Cadet; Alastair J Moss; Nikhil Joshi; Michelle C Williams; Edwin J R van Beek; Damini Dey; Daniel S Berman; David E Newby; Piotr J Slomka; Marc R Dweck Journal: J Am Coll Cardiol Date: 2020-06-23 Impact factor: 24.094
Authors: Evangelos Tzolos; Martin Lyngby Lassen; Tinsu Pan; Jacek Kwiecinski; Sebastien Cadet; Damini Dey; Marc R Dweck; David E Newby; Daniel Berman; Piotr Slomka Journal: J Nucl Cardiol Date: 2020-07-02 Impact factor: 5.952
Authors: Piotr J Slomka; Jonathan B Moody; Robert J H Miller; Jennifer M Renaud; Edward P Ficaro; Ernest V Garcia Journal: J Nucl Cardiol Date: 2020-10-16 Impact factor: 5.952
Authors: Jacek Kwiecinski; Evangelos Tzolos; Mohammed N Meah; Sebastien Cadet; Philip D Adamson; Kajetan Grodecki; Nikhil V Joshi; Alastair J Moss; Michelle C Williams; Edwin J R van Beek; Daniel S Berman; David E Newby; Damini Dey; Marc R Dweck; Piotr J Slomka Journal: J Nucl Med Date: 2021-04-23 Impact factor: 11.082
Authors: Jamie W Bellinge; Roslyn J Francis; Sing Ching Lee; Alistair Vickery; William Macdonald; Seng Khee Gan; Gerard T Chew; Michael Phillips; Joshua R Lewis; Gerald F Watts; Carl J Schultz Journal: J Nucl Cardiol Date: 2021-04-06 Impact factor: 3.872
Authors: Evangelos Tzolos; Jacek Kwiecinski; Martin Lyngby Lassen; Sebastien Cadet; Philip D Adamson; Alastair J Moss; Nikhil Joshi; Michelle C Williams; Edwin J R van Beek; Damini Dey; Daniel S Berman; Marc R Dweck; David E Newby; Piotr J Slomka Journal: J Nucl Cardiol Date: 2020-06-11 Impact factor: 5.952